← Back to Search

CAPS Program for Autism (CAPS Trial)

N/A
Recruiting
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 3, month 12
Awards & highlights

CAPS Trial Summary

This trial will develop and test a novel support service for autistic adults to improve their health and well-being, leveraging existing infrastructure and input from experts.

Who is the study for?
This trial is for English-speaking autistic adults aged 18-30 living in Philadelphia County, who want to improve their social or daily life skills and have a confirmed autism diagnosis. Participants must be able to give informed consent and express challenges in major life areas like social interactions or work.Check my eligibility
What is being tested?
The CAPS program is being tested, which is peer support given by individuals with lived experience of autism. The study aims to develop this novel service further and assess its effectiveness through a pilot randomized controlled trial before larger-scale implementation.See study design
What are the potential side effects?
Since the intervention involves peer-support rather than medication, traditional side effects are not applicable. However, participants may experience varying degrees of emotional discomfort during discussions or while receiving feedback from peers.

CAPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 3, month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 3, month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cognitive Flexibility
Change in Hope
Change in Internalized Stigma
+11 more

CAPS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: experimental armExperimental Treatment1 Intervention
Individuals who receive CAPS
Group II: controlActive Control1 Intervention
Individuals who receive treatment as usual

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
150 Previous Clinical Trials
47,661 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
21,059 Patients Enrolled for Autism Spectrum Disorder
Temple UniversityOTHER
297 Previous Clinical Trials
82,933 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
636 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,659 Total Patients Enrolled
82 Trials studying Autism Spectrum Disorder
40,352 Patients Enrolled for Autism Spectrum Disorder

Media Library

CAPS Clinical Trial Eligibility Overview. Trial Name: NCT05702658 — N/A
Autism Spectrum Disorder Research Study Groups: experimental arm, control
Autism Spectrum Disorder Clinical Trial 2023: CAPS Highlights & Side Effects. Trial Name: NCT05702658 — N/A
CAPS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05702658 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative open to elderly participants?

"Per the regulations of this medical study, only participants between 18 and 30 years old are permitted to enroll."

Answered by AI

Do I qualify to participate in this research trial?

"Those with ASD between 18 and 30 years old are eligible for participation in this trial. 40 patients will be admitted to the study in total."

Answered by AI

Is this experiment currently in need of volunteers?

"Clinicaltrials.gov states that this clinical experiment is no longer accepting patients, having first been posted on January 1st 2023 and last modified on the 18th of January. However, 202 other trials are still recruiting participants at present."

Answered by AI
~3 spots leftby May 2024